RxDoctor Payments Data

Amber Michaeli, PA

Physician Assistant · Salem, ORNPI 1649893785

Payments from drug & device makers

$2,242in general payments, 2019–2025

Across 83 payments — averaging $27.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$402
  • Biotronik Inc.$323
  • Medtronic$291
  • Pfizer$224
  • Alnylam Pharmaceuticals Inc.$192
  • Edwards Lifesciences$127
  • plus $683 from 15 others

What the payments were for

  • Food & beverage$2,14396%
  • Education$994%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,242 in reported general payments places this provider in the 90th percentile of 1,756 physician assistant providers in Oregon.

See all physician assistant providers in Oregon

Medicare billing

Part B allowed, 2024
$24,398
Medicare patients
186
Services billed
303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban325$307,112
JardianceEmpagliflozin66$50,622
XareltoRivaroxaban47$46,529
FarxigaDapagliflozin Propanediol39$33,229
EntrestoSacubitril/Valsartan25$23,738
Digoxin126$4,607
Flecainide Acetate104$3,273
Potassium Chloride145$1,991
SotalolSotalol Hcl88$1,933
Furosemide285$1,900
Metoprolol Succinate153$1,804
Ranolazine ErRanolazine29$1,738
Losartan Potassium99$862
Diltiazem 24hr Er (Cd)Diltiazem Hcl41$859
Diltiazem 24hr ErDiltiazem Hcl33$849

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$224$307,112325 claims
Boehringer IngelheimJardiance$20$50,62266 claims
AstraZenecaFarxiga$28$33,22939 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,756 physician assistant providers in Oregon.

Other physician assistant in Salem

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →